Rituximab-Plasma Exchange Combo Reduced MG Severity

Rituximab-Plasma Exchange Combo Reduced MG Severity

282312

Rituximab-Plasma Exchange Combo Reduced MG Severity

Combination therapy of rituximab and plasma exchange reduced disease severity in nine patients with refractory myasthenia gravis, a case series reports.  The case series, “Treatment of refractory myasthenia gravis by double‐filtration plasmapheresis and rituximab: A case series of nine patients and literature review,” was published in the Journal of Clinical Apheresis.  Myasthenia gravis (MG) is caused by autoantibodies in the body’s immune system attacking components of the neuromuscular junctions — the sites where nerves and muscle cells…

You must be logged in to read/download the full post.